April 21, 2018 12:37 PM ET


Company Overview of LakePharma, Inc.

Company Overview

LakePharma, Inc. operates as a biotechnology company that provides biologics discovery and development services. It offers services in the areas of molecular biology, antibody discovery, antibody engineering, antibody production, antibody functional characterization, protein engineering and production, protein chemistry, cell line development, bioassay, bioanalytical, biomanufacturing, and integrated solutions. The company was founded in 2009 and is based in Belmont, California with locations in South San Francisco and Hayward, California; and Worcester and Hopkinton, Massachusetts.

520 Harbor Boulevard

Belmont, CA 94002

United States

Founded in 2009





Key Executives for LakePharma, Inc.

Founder & CEO
Chief Financial Officer
General Counsel
Vice President of Client Resources
Vice President of Antibody Discovery
Compensation as of Fiscal Year 2017.

LakePharma, Inc. Key Developments

LakePharma Appoints David Boyle as Chief Financial Officer

LakePharma, Inc. announced the appointment of David Boyle as Chief Financial Officer of the company. Prior to LakePharma, David Boyle served as Chief Financial Officer at Direct Flow Medical, AVI BioPharma, and XOMA Ltd., and was Executive Vice President and Chief Financial Officer at Salix Pharmaceuticals. Boyle also served in various finance, administration, and development leadership roles at Serono, Intel, and Polycom, Inc.

LakePharma, Inc. Announces the Launch of LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA

LakePharma, Inc. announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA. Located at 35 South Street, the newly-acquired 69,000-square foot building includes laboratory, office space and infrastructure for GMP manufacturing. LakePharma intends to develop the site to perform GMP biologics manufacturing for Phase 1 clinical trials. The increased capacity at the site will also support growth in LakePharma's assay development, bioanalytical, process development and QC services. The company plans to add approximately 100 positions at the Center by 2020.

Hemogenyx Pharmaceuticals Plc Appoints LakePharma, Inc. as Service Provider for Lead Drug Development

Hemogenyx Pharmaceuticals Plc announced that it has chosen LakePharma, Inc. as its service provider for the development and manufacturing of Hemogenyx's lead product, CDX bi-specific antibodies. The company believes that CDX bi-specific antibodies could replace traditional methods of conditioning patients for bone marrow transplants-eliminating the need for pre-transplantation chemotherapy and radiation, which can damage a patient's health-and allow more patients to benefit from the curative power of bone marrow transplants. The relationship between Hemogenyx Pharmaceuticals and LakePharma is designed to have a seamless product development process, from discovery to biomanufacturing, as Hemogenyx moves its cutting-edge therapies toward clinical trials. Strategically, the formalization of this relationship is particularly significant because it marks a major step in the pre-clinical development of Hemogenyx's CDX antibodies. Undertaken with the expertise and validated technology of LakePharma, the US-based biologics contract research organization, this step brings Hemogenyx significantly closer to its goal of taking the CDX antibodies into clinical trials at the earliest opportunity with a faster path through pre-clinical trials.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Private Placement
December 12, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LakePharma, Inc., please visit lakepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.